Tenderwize
Back to tender search

Pazopanib medicines

AOK Sachsen - Anhalt·Magdeburg, Germany·Deadline Oct 30, 2027 · 344 days left·Open·Supplies
Original notice title

Germany – Pharmaceutical products – Arzneimittel mit dem Wirkstoff Pazopanib (ATC: L01EX03)

63/100

Opportunity Score

Needs reviewMedium complexity
SuppliesOpen
Why this score?

Opportunity

63 / 100

Complexity

58 / 100

Risk factors

The notice provides no estimated value, guaranteed volume, demand forecast, or minimum purchase commitment.

Contracts may be terminated under their contractual provisions if AOK Sachsen-Anhalt later awards exclusive contracts f...

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Tender facts

Contracting authority
AOK Sachsen - Anhalt
Country
Germany
CPV
33600000 - Pharmaceutical products
Deadline
Oct 30, 2027

Overview

Moderate opportunity

Key Facts

  • Supplies contract
  • 1 lot
  • Duration 2 YEAR
  • Conclusion of non-exclusive rebate agreements under §130a(8) SGB V for finished medicinal products containing Pazopanib (ATC L01EX03).
  • Open-house access for all suitable and interested pharmaceutical companies or communities of pharmaceutical companies that satisfy the participation requirements.
Show full summary

Open-house arrangement for non-exclusive pharmaceutical rebate agreements concerning finished medicinal products containing Pazopanib (ATC L01EX03), under §130a(8) SGB V. Every pharmaceutical company or pharmaceutical-company community meeting the participation requirements may conclude the same contract; there is no exclusivity or individual negotiation. The contract may start from 1 January 2026, lasts up to 24 months, and ends on 31 December 2027. No contract value is provided. Procurement documents were not analyzed; only the structured notice and extracted TED XML notice were available.

Risks

The notice provides no estimated value, guaranteed volume, demand forecast, or minimum purchase commitment.

Contracts may be terminated under their contractual provisions if AOK Sachsen-Anhalt later awards exclusive contracts f...

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Technical

  • The agreement concerns supplies of pharmaceutical products for performance in Germany.

Administrative

  • The interested pharmaceutical company must request the participation documents and the relevant contract from the stated contact address.
  • Participation documents must be completed in full and signed.

Buyer

Location

Magdeburg, DEU

Buyer profile

Open profile

Identifier

DE258393558

Activity

Health

Lots (1)

LOT-0001

Pazopanib Medicinal Products

Non-exclusive rebate agreement for finished medicinal products containing Pazopanib (ATC L01EX03) under an open-house model. Eligible pharmaceutical companies may join at any time on identical conditions. No exclusivity or individual negotiation is provided. The lot information is derived from structured tender data and the extracted TED XML notice.

SuppliesEU fundedElectronic submission

Location

DEE03, Germany

Duration

2 YEAR

Category

Pharmaceutical products

Deadline

Deadline Oct 30, 2027

Procurement Details

Publication date
18 Nov 2025
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
765867-2025

Documents (1)

Similar tenders

Cookies & Privacy

With your consent, we use Google Analytics, Microsoft Clarity (session recordings) and Google Ads cookies to understand how Tenderwize is used and to measure our advertising. You can change your choice at any time via “Cookie Settings” in the footer. Cookie Policy · Privacy Policy